KARINA LYNCH
KARINA LYNCH is named as a lobbyist in 24 lobbying reports we hold, filed by 1 registrant for 23 clients.
Earlier government jobs, as reported
A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.
No report we hold lists a covered position for KARINA LYNCH.
Registrants and clients
- DLA PIPER LLP (US) · 24 reports
Clients: PONYA DIAGNOSTICS, LLC; ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED); AVALYN PHARMA INC.; BIOGEN, INC.; BIOHAVEN PHARMACEUTICALS, INC.; BIOTECHNOLOGY INNOVATION ORGANIZATION; BOSTON DYNAMICS, INC.; CORVENT MEDICAL, INC.; CROWDSTRIKE, INC.; DUKE UNIVERSITY; GALDERMA LABORATORIES, L.P.; MANHATTAN ASSOCIATES, INC.; NOVARTIS; PARTICULA GROUP INC.; PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA; REGENXBIO INC.; RESEARCH SOCIETY ON ALCOHOL; THE JED FOUNDATION; THE NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES; UNITED WAY WORLDWIDE; UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS); XEROX HOLDINGS CORPORATION.
Bills named where this lobbyist is listed, and how the House and the Senate voted
16 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1672Maintaining Investments in New Innovation Act | Introduced | No recorded vote in our record |
| H.R. 3633Digital Asset Market Clarity Act | Passed the House | No recorded vote in our record |
| H.R. 4312SCORE Act | Reported by committee | No recorded vote in our record |
| H.R. 5133Patients’ Right to Know Their Medication Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 7334National Commission on Robotics Act | Introduced | No recorded vote in our record |
| H.R. 8189American Security Robotics Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 8800National Defense Authorization Act for Fiscal Year 2027 | Passed the House | No recorded vote in our record |
| H.R. 9129GUARD Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9260Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| H.R. 9310Department of Homeland Security Appropriations Act, 2027 | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 3275Humanoid ROBOT Act of 2025 | Introduced | No recorded vote in our record |
| S. 4235American Security Robotics Act of 2026 | Introduced | No recorded vote in our record |
| S. 4668Protect College Sports Act of 2026 | Passed the Senate | No recorded vote in our record |
| S. 4686National Commission on Robotics Act | Introduced | No recorded vote in our record |
Issues named: Health Issues (13), Medicare/Medicaid (8), Medical/Disease Research/Clinical Labs (7), Pharmacy (5), Trade (domestic/foreign) (4), Budget/Appropriations (3), Copyright/Patent/Trademark (3), Education (3), Taxation/Internal Revenue Code (3), Defense (2), Homeland Security (2), Veterans (2), and 5 mores.
Every report
| Client | Registrant | Kind, as filed | Posted | Report |
|---|---|---|---|---|
| PONYA DIAGNOSTICS, LLCMedicare/Medicaid, Medical/Disease Research/Clinical Labs, Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Amendment | The report on LDA.gov | |
| GALDERMA LABORATORIES, L.P.Pharmacy, Trade (domestic/foreign) | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICACopyright/Patent/Trademark, Budget/Appropriations, Defense, Trade (domestic/foreign), Pharmacy, Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| NOVARTISCopyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues, Medicare/Medicaid | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| BIOGEN, INC.Pharmacy, Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code, Trade (domestic/foreign) | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| BOSTON DYNAMICS, INC.Manufacturing | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| BIOHAVEN PHARMACEUTICALS, INC.Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| MANHATTAN ASSOCIATES, INC.Homeland Security | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| RESEARCH SOCIETY ON ALCOHOLAlcohol and Drug Abuse, Budget/Appropriations | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| THE JED FOUNDATIONEducation, Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLEducation | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| UNITED WAY WORLDWIDEHealth Issues, Housing, Disaster Planning/Emergencies | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS)Defense, Veterans, Medicare/Medicaid | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| DUKE UNIVERSITYEducation, Taxation/Internal Revenue Code | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| PARTICULA GROUP INC.Financial Institutions/Investments/Securities | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| PONYA DIAGNOSTICS, LLCMedicare/Medicaid, Medical/Disease Research/Clinical Labs, Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)Medicare/Medicaid, Medical/Disease Research/Clinical Labs | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| BIOTECHNOLOGY INNOVATION ORGANIZATIONMedical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| REGENXBIO INC.Health Issues, Medical/Disease Research/Clinical Labs | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| AVALYN PHARMA INC.Medical/Disease Research/Clinical Labs, Health Issues | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| THE NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIESHealth Issues, Budget/Appropriations, Medicare/Medicaid | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| CORVENT MEDICAL, INC.Health Issues, Veterans | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| CROWDSTRIKE, INC.Homeland Security | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov | |
| XEROX HOLDINGS CORPORATIONPharmacy | DLA PIPER LLP (US) | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this lobbyist reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.